Lung cancer - Critical Therapeutics Completes Dosing of First Patient in Clinical

Critical Therapeutics Completes Dosing of First Patient in Clinical
Genetic Engineering News - Critical Therapeutics, Inc. (Nasdaq: CRTX) today announced that it has enrolled and dosed the first patient in its Phase I/II clinical trial of intravenous (IV) zileuton in patients with asthma. The double-blind, placebo-controlled, single-dose trial

Druce decision
WHP CBS21 - WHP CBS 21 is proud to air Educational and Informational programming for children. Our Children's Television Programming report is available for review during regular business hours 8:30AM to 5:00PM Monday thru Friday at our studio: 3300 North Sixth

Jurors award $1.86 million in derailment case
Independent Record - MINNEAPOLIS Canadian Pacific Railway must pay four people nearly $1.86 million for injuries they suffered as a result of a 2002 derailment near Minot, N.D., that spilled a cloud of anhydrous ammonia, a jury decided Wednesday. The railroad had